Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

347

HTML

2784

Figures (1-3)

208

Tables (1-1)

206

Sum=3545

Mar 7, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 7, 2006; 12(9): 1412-1415
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1412

Full Size Figure Download Figure

Figure 2 Concentrations of PTX in plasma and ascites in case 2 administrated with 80 mg/m2 PTX intravenously for 1. 5 h.

Citation: Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, Araki K. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol 2006; 12(9): 1412-1415
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1412.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i9.1412